3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
10
Colorectal Neoplasms
5
Stomach Neoplasms
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Biliary Tract Neoplasms
3
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Recurrence
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Wilms Tumor
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Malignant Ascites
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Paclitaxel
2
Nivolumab
2
Immunoglobulin G
2
Disulfides
2
Bevacizumab
2
atezolizumab
1
Taxes
1
Specimen Handling
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Ipilimumab
1
Gemcitabine
1
Fluorouracil
1
Famotidine
1
Docetaxel
1
Diphenhydramine
1
Dexamethasone
1
Carboplatin
1
Calcium Dobesilate
1
CTLA-4 Antigen
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Mucinous
×
irinotecan sucrosofate
×
1 year
×
Clear all
No trials found.